Neuroradiology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 24, 2025
In
primary
central
nervous
system
lymphoma
(PCNSL),
B-cell
lymphoma-6
(BCL-6)
is
an
unfavorable
prognostic
biomarker.
We
aim
to
non-invasively
detect
BCL-6
overexpression
in
PCNSL
patients
using
multiparametric
MRI
and
machine
learning
techniques.
65
(101
lesions)
with
(PCNSL)
diagnosed
from
January
2013
July
2023,
all
were
randomly
divided
into
a
training
set
validation
according
ratio
of
8
2.
ADC
map
derived
DWI
(b
=
0/1000
s/mm2),
fast
spin
echo
T2WI,
T2FLAIR,
collected
at
3.0
T.
A
total
2234
radiomics
features
the
tumor
segmentation
area
extracted
LASSO
used
select
features.
Logistic
regression
(LR),
Naive
bayes
(NB),
Support
vector
(SVM),
K-nearest
Neighbor,
(KNN)
Multilayer
Perceptron
(MLP),
for
learning,
sensitivity,
specificity,
accuracy
F1-score,
under
curve
(AUC)
was
evaluate
detection
performance
five
classifiers,
6
groups
combinations
different
sequences
fitted
5
optimal
classifier
obtained.
status
could
be
identified
varying
degrees
30
models
based
on
radiomics,
model
improved
by
combining
classifiers.
(SVM)
combined
three
sequence
group
had
largest
AUC
(0.95)
satisfactory
(0.87)
set.
Multiparametric
promising
detecting
overexpression.
BMC Medical Informatics and Decision Making,
Journal Year:
2023,
Volume and Issue:
23(1)
Published: Jan. 23, 2023
Detecting
brain
tumors
in
their
early
stages
is
crucial.
Brain
are
classified
by
biopsy,
which
can
only
be
performed
through
definitive
surgery.
Computational
intelligence-oriented
techniques
help
physicians
identify
and
classify
tumors.
Herein,
we
proposed
two
deep
learning
methods
several
machine
approaches
for
diagnosing
three
types
of
tumor,
i.e.,
glioma,
meningioma,
pituitary
gland
tumors,
as
well
healthy
brains
without
using
magnetic
resonance
images
to
enable
detect
with
high
accuracy
stages.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(9), P. 7781 - 7781
Published: April 24, 2023
The
identification
of
biomarkers
plays
a
crucial
role
in
personalized
medicine,
both
the
clinical
and
research
settings.
However,
contrast
between
predictive
prognostic
can
be
challenging
due
to
overlap
two.
A
biomarker
predicts
future
outcome
cancer,
regardless
treatment,
effectiveness
therapeutic
intervention.
Misclassifying
as
(or
vice
versa)
have
serious
financial
personal
consequences
for
patients.
To
address
this
issue,
various
statistical
machine
learning
approaches
been
developed.
aim
study
is
present
an
in-depth
analysis
recent
advancements,
trends,
challenges,
prospects
identification.
systematic
search
was
conducted
using
PubMed
identify
relevant
studies
published
2017
2023.
selected
were
analyzed
better
understand
concept
identification,
evaluate
methods,
assess
level
activity,
highlight
application
these
methods
cancer
treatment.
Furthermore,
existing
obstacles
concerns
are
discussed
prospective
areas.
We
believe
that
review
will
serve
valuable
resource
researchers,
providing
insights
into
used
discovery
identifying
opportunities.
Frontiers in Oncology,
Journal Year:
2021,
Volume and Issue:
11
Published: Aug. 18, 2021
To
investigate
whether
radiomics
features
extracted
from
multi-parametric
MRI
combining
machine
learning
approach
can
predict
molecular
subtype
and
androgen
receptor
(AR)
expression
of
breast
cancer
in
a
non-invasive
way.Patients
diagnosed
with
clinical
T2-4
stage
March
2016
to
July
2020
were
retrospectively
enrolled.
The
subtypes
AR
pre-treatment
biopsy
specimens
assessed.
A
total
4,198
the
pre-biopsy
(including
dynamic
contrast-enhancement
T1-weighted
images,
fat-suppressed
T2-weighted
apparent
diffusion
coefficient
map)
each
patient.
We
applied
several
feature
selection
strategies
including
least
absolute
shrinkage
operator
(LASSO),
recursive
elimination
(RFE),
maximum
relevance
minimum
redundancy
(mRMR),
Boruta
Pearson
correlation
analysis,
select
most
optimal
features.
then
built
120
diagnostic
models
using
distinct
classification
algorithms
sets
divided
by
sequences
testing
dataset
leave-one-out
cross-validation
(LOOCV).
performances
binary
assessed
via
area
under
receiver
operating
characteristic
curve
(AUC),
accuracy,
sensitivity,
specificity,
positive
predictive
value
(PPV),
negative
(NPV).
And
multiclass
AUC,
overall
precision,
recall
rate,
F1-score.A
162
patients
(mean
age,
46.91
±
10.08
years)
enrolled
this
study;
30
low-AR
132
high-AR
expression.
HR+/HER2-
cancers
56
cases
(34.6%),
HER2+
81
(50.0%),
TNBC
25
(15.4%).
There
was
no
significant
difference
clinicopathologic
characteristics
between
groups
(P
>
0.05),
except
menopausal
status,
ER,
PR,
HER2,
Ki-67
index
=
0.043,
<0.001,
0.015,
0.006,
respectively).
No
observed
among
three
status
<0.001
0.012,
Multilayer
Perceptron
(MLP)
showed
best
performance
discriminating
expression,
an
AUC
0.907
accuracy
85.8%
dataset.
highest
obtained
for
vs.
non-TNBC
(AUC:
0.965,
accuracy:
92.6%),
HER2-
0.840,
79.0%),
others
0.860,
82.1%)
MLP
as
well.
micro-AUC
model
0.896,
0.735.Multi-parametric
MRI-based
approaches
provide
promising
method
non-invasively.
npj Breast Cancer,
Journal Year:
2023,
Volume and Issue:
9(1)
Published: March 22, 2023
Accurately
determining
the
molecular
subtypes
of
breast
cancer
is
important
for
prognosis
patients
and
can
guide
treatment
selection.
In
this
study,
we
develop
a
deep
learning-based
model
predicting
directly
from
diagnostic
mammography
ultrasound
images.
Multi-modal
learning
with
intra-
inter-modality
attention
modules
(MDL-IIA)
proposed
to
extract
relations
between
task.
MDL-IIA
leads
best
performance
compared
other
cohort
models
in
4-category
Matthews
correlation
coefficient
(MCC)
0.837
(95%
confidence
interval
[CI]:
0.803,
0.870).
The
also
discriminate
Luminal
Non-Luminal
disease
an
area
under
receiver
operating
characteristic
curve
0.929
CI:
0.903,
0.951).
These
results
significantly
outperform
clinicians'
predictions
based
on
radiographic
imaging.
Beyond
molecular-level
test,
gene-level
ground
truth,
our
method
bypass
inherent
uncertainty
immunohistochemistry
test.
This
work
thus
provides
noninvasive
predict
cancer,
potentially
guiding
selection
providing
decision
support
clinicians.
Patterns,
Journal Year:
2023,
Volume and Issue:
4(9), P. 100826 - 100826
Published: Aug. 16, 2023
Dynamic
contrast-enhanced
magnetic
resonance
imaging
(DCE-MRI)
allows
screening,
follow
up,
and
diagnosis
for
breast
tumor
with
high
sensitivity.
Accurate
segmentation
from
DCE-MRI
can
provide
crucial
information
of
location
shape,
which
significantly
influences
the
downstream
clinical
decisions.
In
this
paper,
we
aim
to
develop
an
artificial
intelligence
(AI)
assistant
automatically
segment
tumors
by
capturing
dynamic
changes
in
multi-phase
a
spatial-temporal
framework.
The
main
advantages
our
AI
include
(1)
robustness,
i.e.,
model
handle
MR
data
different
phase
numbers
intervals,
as
demonstrated
on
large-scale
dataset
seven
medical
centers,
(2)
efficiency,
reduces
time
required
manual
annotation
factor
20,
while
maintaining
accuracy
comparable
that
physicians.
More
importantly,
fundamental
step
build
AI-assisted
cancer
system,
will
promote
application
more
diagnostic
practices
regarding
cancer.
Scientific Reports,
Journal Year:
2023,
Volume and Issue:
13(1)
Published: April 15, 2023
Abstract
Gastric
cancer
is
the
high
mortality
rate
cancers
globally,
and
current
survival
30%
even
with
use
of
combination
therapies.
Recently,
mounting
evidence
indicates
potential
role
miRNAs
in
diagnosis
assessing
prognosis
cancers.
In
state-of-art
research
cancer,
machine-learning
(ML)
has
gained
increasing
attention
to
find
clinically
useful
biomarkers.
The
present
study
aimed
identify
diagnostic
prognostic
GC
application
ML.
Using
TCGA
database
ML
algorithms
such
as
Support
Vector
Machine
(SVM),
Random
Forest,
k-NN,
etc.,
a
panel
29
was
obtained.
Among
algorithms,
SVM
chosen
(AUC:88.5%,
Accuracy:93%
GC).
To
common
molecular
mechanisms
miRNAs,
their
gene
targets
were
predicted
using
online
databases
miRWalk,
miRDB,
Targetscan.
Functional
enrichment
analyzes
performed
Gene
Ontology
(GO)
Kyoto
Database
Genes
Genomes
(KEGG),
well
identification
protein–protein
interactions
(PPI)
STRING
database.
Pathway
analysis
target
genes
revealed
involvement
several
cancer-related
pathways
including
miRNA
mediated
inhibition
translation,
regulation
expression
by
genetic
imprinting,
Wnt
signaling
pathway.
Survival
ROC
curve
showed
that
levels
hsa-miR-21,
hsa-miR-133a,
hsa-miR-146b,
hsa-miR-29c
associated
higher
potentially
earlier
detection
patients.
A
dysregulated
may
serve
reliable
biomarkers
for
gastric
identified
machine
learning,
which
represents
powerful
tool
biomarker
identification.
Frontiers in Oncology,
Journal Year:
2025,
Volume and Issue:
15
Published: Feb. 20, 2025
With
the
rapid
development
of
"Internet
+
Medical"
model,
artificial
intelligence
technology
has
been
widely
used
in
analysis
medical
images.
Among
them,
using
deep
learning
algorithms
to
identify
features
ultrasound
and
pathological
images
realize
intelligent
diagnosis
diseases
entered
clinical
verification
stage.
This
study
is
based
on
application
research
reviews
early
screening
thyroid
diseases.
The
cure
rate
disease
high
stage,
but
once
it
deteriorates
into
cancer,
risk
death
treatment
costs
patient
increase.
At
present,
still
depends
examination
equipment
experience
doctors,
there
a
certain
misdiagnosis
rate.
Based
above
background,
particularly
important
explore
that
can
achieve
objective
lesions
stages.
paper
provides
comprehensive
review
recent
technology.
It
integrates
findings
multiple
studies
traditional
machine
are
as
objects.
convolutional
neural
network
model
recognition
accuracy
for
nodules
cell
lesions.
U-Net
significantly
improve
nodule
when
segmentation
algorithm.
article
focuses
reviewing
sections,
hoping
provide
researchers
with
ideas
help
clinicians
cancer.